Mednax 2021 third quarter conference call / webcast scheduled for Thursday, October 28, 2021 | 2021-10-18 | Press Releases

0

Mednax, Inc. (NYSE: MD) will host an investor conference call and webcast on Thursday, October 28, 2021 at 9 a.m. ET, to discuss operating results for the quarter and nine months ended September 30, 2021. news release release will be published on the morning of October 28, 2021 before the opening of the securities markets.

The investor conference call will be webcast and be accessible on the Mednax website ‘ www.mednax.com/investisseurs.

ABOUT MEDNAX

Mednax, Inc. is a national medical group comprised of the nation’s leading medical service providers. Physicians and advanced practitioners in Mednax’s Pediatrix and Obstetrix medical groups are reshaping the delivery of care in their specialties and subspecialties, using evidence-based tools, continuous quality initiatives, research agendas clinic and telehealth to improve patient outcomes and provide cost-effective, quality care. The company was founded in 1979 and today, through its affiliated professional entities, Mednax provides services through a network of more than 2,300 physicians in 39 states and Puerto Rico. Further information is available at www.mednax.com.

Certain statements and information contained in this press release may be deemed to contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act & CloseCurlyDoubleQuote;), and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may include, without limitation, statements relating to the objectives, plans and strategies of the company, and all statements, other than statements of historical fact, which relate to activities, events or developments. that we intend, expect, project, believe or anticipate will or could occur in the future. These statements are often characterized by terminology such as “believe,” “I hope,” “may,” “anticipate,” “should,” “intention,” “plan,” “will,” “wait,” “estimate , “” Project, “” positioned, “” strategy & CloseCurlyDoubleQuote; and similar expressions, and are based on assumptions and assessments made by the management of the Company in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they deem appropriate. All forward-looking statements contained in this press release are made as of the date hereof, and the Company assumes no obligation to update or revise such statements, whether as a result of new information, future events. or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are described in the company’s most recent annual report on Form 10-K and its quarterly reports on Form 10 -Q, including the sections titled “Risk Factors & CloseCurlyDoubleQuote ;, as well as the Company’s current reports & CloseCurlyQuote; on Form 8-K, filed with the Securities and Exchange Commission, and include the impact of the COVID-19 pandemic on the Company, its financial condition and its results of operations; the effects of economic conditions on the activities of the Company; the effects of the Affordable Care Act and its potential amendments or repeal; the relations of the Company and CloseCurlyQuote; with government sponsored or funded health care programs, including Medicare and Medicaid, and with managed care organizations and commercial health insurance payers; the Company’s ability to comply with the terms of its debt financing agreements; the company’s transition to a third-party revenue cycle management provider; the impact of the sale of the Company’s medical anesthesiology and radiology groups; the impact of management transitions; the timing and contribution of future acquisitions; the effects of share buybacks; and the effects of the Company’s transformation initiatives, including its reorientation and growth strategy for its pediatrics and obstetrics businesses.


Source link

Share.

Leave A Reply